CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 39 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,412,000 | -22.8% | 724,455 | -30.2% | 0.00% | -25.0% |
| Q3 2016 | $5,717,000 | +43.7% | 1,037,567 | -0.9% | 0.00% | +33.3% |
| Q2 2016 | $3,978,000 | +359.4% | 1,046,946 | +233.6% | 0.00% | +200.0% |
| Q1 2016 | $866,000 | -58.4% | 313,801 | -20.1% | 0.00% | -50.0% |
| Q3 2015 | $2,083,000 | – | 392,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 1,132,737 | $1,399,000 | 0.21% |
| Prospera Financial Services Inc | 177,550 | $215,000 | 0.05% |
| LBA Wealth Management, LLC | 12,000 | $15,000 | 0.01% |
| Cambridge Investment Research Advisors, Inc. | 23,457 | $28,000 | 0.00% |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 313,801 | $866,000 | 0.00% |
| TEACHERS ADVISORS, LLC | 148,551 | $410,000 | 0.00% |
| Balentine LLC | 55 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 177 | $0 | 0.00% |
| Vantage Investment Advisors, LLC | 1,150 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 5,453 | $7,000 | 0.00% |